Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome

Henk Jan Boiten^*, Michiel Buijze, Sonja Zweegman, Mark David Levin

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Journal	Clinical Lymphoma, Myeloma and Leukemia
DOIs	https://doi.org/10.1016/j.clml.2020.06.016
Publication status	Accepted/In press - 1 Jan 2020

Cite this

@article{dc5b49ccf382483e82d464741d1a773a,

title = "Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome",

keywords = "Dyspnea, Hyperviscosity syndrome, Ixazomib, Multiple myeloma, Therapeutic apheresis",

author = "Boiten, {Henk Jan} and Michiel Buijze and Sonja Zweegman and Levin, {Mark David}",

year = "2020",

month = "1",

day = "1",

doi = "10.1016/j.clml.2020.06.016",

language = "English",

journal = "Clinical Lymphoma Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

}

TY - JOUR

T1 - Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome

AU - Boiten, Henk Jan

AU - Buijze, Michiel

AU - Zweegman, Sonja

AU - Levin, Mark David

PY - 2020/1/1

Y1 - 2020/1/1

KW - Dyspnea

KW - Hyperviscosity syndrome

KW - Ixazomib

KW - Multiple myeloma

KW - Therapeutic apheresis

UR - http://www.scopus.com/inward/record.url?scp=85088145189&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2020.06.016

DO - 10.1016/j.clml.2020.06.016

M3 - Article

C2 - 32690387

AN - SCOPUS:85088145189

JO - Clinical Lymphoma Myeloma and Leukemia

JF - Clinical Lymphoma Myeloma and Leukemia

SN - 2152-2650

ER -